DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Gem Aromatics Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 42 min ago·20 Aug 2026, 6:44 am

GEM Aromatics

Gem Aromatics Limited has informed stock exchanges that the transcript from its recent analyst and institutional investor meet is now available. This document provides a detailed record of the questions asked and the answers provided by the company's management during the interaction.

For investors, this transcript is a valuable tool. It offers transparency into management's outlook, future strategy, and answers to specific concerns raised by the market. It helps retail investors understand the company's narrative better than just the headline numbers.

Investors should review the transcript to gauge management's tone and clarity. Watch for updates on production capacity, export orders, and margin commentary to assess the company's growth trajectory and operational health.